BIVRX vs. QAMNX
BIVRX (Invenomic Fund) and QAMNX (Federated Hermes MDT Market Neutral A) are both Long-Short funds. Over the past 3 years, BIVRX returned -0.37%/yr vs 11.22%/yr for QAMNX. At a 0.08 correlation, their price movements are largely independent. BIVRX charges 2.48%/yr vs 1.86%/yr for QAMNX.
Performance
BIVRX vs. QAMNX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIVRX achieves a -2.13% return, which is significantly lower than QAMNX's 1.69% return.
BIVRX
- 1D
- 3.28%
- 1M
- 14.42%
- 6M
- 3.41%
- YTD
- -2.13%
- 1Y
- 5.20%
- 3Y*
- -0.37%
- 5Y*
- 10.52%
- 10Y*
- —
QAMNX
- 1D
- -0.05%
- 1M
- 2.61%
- 6M
- 3.64%
- YTD
- 1.69%
- 1Y
- 5.42%
- 3Y*
- 11.22%
- 5Y*
- —
- 10Y*
- —
BIVRX vs. QAMNX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | -2.13% | 4.39% | -9.03% | 16.47% | 49.61% | 6.94% |
QAMNX Federated Hermes MDT Market Neutral A | 1.69% | 10.00% | 17.33% | 4.71% | 9.19% | 12.29% |
Correlation
The correlation between BIVRX and QAMNX is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2021 | 0.08 |
The correlation between BIVRX and QAMNX shifts across timeframes, from -0.02 (3 years) to 0.24 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIVRX vs. QAMNX — Risk / Return Rank
BIVRX
QAMNX
BIVRX vs. QAMNX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and Federated Hermes MDT Market Neutral A (QAMNX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIVRX | QAMNX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.56 | ||
| Sortino ratioReturn per unit of downside risk | -0.61 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.14 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | 1.13 | -0.97 |
| Martin ratioReturn relative to average drawdown | 0.44 | 2.50 | -2.05 |
Loading charts...
Drawdowns
BIVRX vs. QAMNX - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -27.37%, which is greater than QAMNX's maximum drawdown of -17.97%. Use the drawdown chart below to compare losses from any high point for BIVRX and QAMNX.
Loading charts...
Drawdown Indicators
| BIVRX | QAMNX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.37% | -17.97% | -9.40% |
Max Drawdown (1Y)Largest decline over 1 year | -26.97% | -4.16% | -22.81% |
Max Drawdown (3Y)Largest decline over 3 years | -27.37% | -4.16% | -23.21% |
Max Drawdown (5Y)Largest decline over 5 years | -27.37% | — | — |
Current DrawdownCurrent decline from peak | -8.72% | -0.37% | -8.35% |
Average DrawdownAverage peak-to-trough decline | -6.20% | -5.07% | -1.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.90% | 1.90% | +8.00% |
Volatility
BIVRX vs. QAMNX - Volatility Comparison
Invenomic Fund (BIVRX) has a higher volatility of 17.61% compared to Federated Hermes MDT Market Neutral A (QAMNX) at 1.79%. This indicates that BIVRX's price experiences larger fluctuations and is considered to be riskier than QAMNX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIVRX | QAMNX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.61% | 1.79% | +15.82% |
Volatility (6M)Calculated over the trailing 6-month period | 26.71% | 4.52% | +22.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.40% | 6.70% | +23.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.26% | 13.72% | +5.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.56% | 13.72% | +4.84% |
BIVRX vs. QAMNX - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than QAMNX's 1.86% expense ratio.
Dividends
BIVRX vs. QAMNX - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 1.97%, more than QAMNX's 1.50% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 1.97% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% |
QAMNX Federated Hermes MDT Market Neutral A | 1.50% | 1.53% | 1.85% | 5.89% | 11.74% | 20.80% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIVRX and QAMNX have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIVRX has higher volatility (17.61%) compared to QAMNX (1.79%). In terms of maximum drawdown, BIVRX dropped -27.37% vs QAMNX's -17.97%.
QAMNX currently has the higher Sharpe Ratio (0.70 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIVRX and QAMNX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer